INTRODUCTION
The WWOX gene (WW domain-containing oxidoreductase[MIM 605131]) is a tumor suppressor gene that have been associated with several types of cancer such as breast, hepatic, lung, prostate, ovarian, colon, gastric, and esophageal carcinomas [1] [2] [3] [4] [5] [6] [7] [8] [9] . The WWOX gene is located on chromosome 16q23 and encodes 414 amino acids protein (46 kDa), which contains two N-terminal WW domains that has highly conserved proline and tryptophan residues responsible of mediating protein-protein interactions, a short chain of dehydrogenase reductase domain at the C-terminal, and a nuclear localization sequence [2, 10, 11] .
When cells are exposed to apoptotic stresses, WWOX is up-regulated and activated by pY33 phosphorylation via Tyrosine Kinase Src [12, 13] . The pY33-WWOX act as cancer suppressor by inhibiting tumor growth and supporting normal cell physiology [14] . On the other hand, phosphorylation of Ser14 in the WWOX protein is necessary for T cell maturation [15] . However, WWOX lose the tumor suppression function when Ser14 is phosphorylated and involved in cancer progression, but when mouse model of melanoma is treated with Zfra (a WWOX inhibitor) the cancer cell growth and metastasis is blocked [16, 17] .
Recently, several studies indicated an important role of WWOX in neuronal development, function, and diseases [18] [19] [20] [21] .
Gribaa and colleagues, identified two WWOX homozygous mutations in highly conserved residues p.Pro47Thr and p.Gly372Arg in two consanguineous Saudi family resulting in autosomal recessive cerebellar ataxia with epilepsy and mental retardation [22, 23] . They demonstrated that the proline residue at position 47 is part of the hydrophobic core that stabilizes the WW fold and required to maintain the WWOX protein fully functional [23] . An additional two nonsense mutations have been identified a W44* and Arg54*, which result in non-functional protein and lead to intractable seizures and early lethal microcephaly syndrome with epilepsy respectively [24, 25] .
In this study we investigated two consanguineous Saudi families and we identified three affected children with epileptic encephalopathy. One patient had a novel homozygous mutation that has not been previously described in the WWOX gene. 
Sanger sequencing
The findings were confirmed by PCR and sequencing of both DNA strands of the entire coding region and the highly conserved exonintron splice junctions. Whole exome sequencing revealed previously reported homozygous mutation at genomic location c.160G > T (p.Arg54*) [24] , which resulted in a premature termination.
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Patient 3
18 months old female (sister of patient 2).
She is a product of full-term pregnancy and normal vaginal delivery. She was admitted to NICU for 5 days secondary to suspected sepsis. At age of 2 months she became hypoactive and the symptom progressed gradually. She In the second family, we identified a previously reported mutation R54* in two siblings, which created a stop codon and resulted in premature termination. AbdelSalam and collages were the first group to report this mutation. The main clinical phenotypes were severe syndrome of growth retardation, microcephaly, epileptic seizures, retinopathy and early death [24] .
WWOX is a cytoplasmic protein that is 
Conclusion
In conclusion, we have identified two consanguineous Saudi families with one novel intronic mutation and one previously reported mutation at the WW domain. The intronic mutation is predicted to result in either exon skipping or including the intron in the protein sequence. Thus, this may lead to frame shift and alter the protein sequence or result in premature protein termination. Further functional studies are needed to understand the underlying mechanism of WWOX associated epilepsy.
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